Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.


Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy


Arrhythmia & Electrophysiology Review 2017;6(2):63–8.

Is There a Future for Remote Cardiac Implantable Electronic Device Management?


Arrhythmia & Electrophysiology Review 2017;6(3):109–10.

Periodic Repolarisation Dynamics Assessment for Risk Prediction


Arrhythmia & Electrophysiology Review 2016;5(1):31–6

Post-extrasystolic Potentiation: Link between Ca2+ Homeostasis and Heart Failure?


Arrhythmia & Electrophysiology Review 2016;5(1):20–6